Context Therapeutics Inc. (CNTX) Stock Grade

About Context Therapeutics Inc.'s fundamentals

Context Therapeutics is a small-cap biotechnology company with a market capitalization of $30.0 million that is currently unprofitable, having reported a net loss in its latest annual statement. The company generated no revenue growth year-over-year and operates with a net margin of 0.0%, indicating it is not yet generating positive earnings from operations. Traditional valuation metrics like price-to-earnings ratio and return on equity are not applicable given the company's loss-making status, and the company does not pay a dividend.